These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23630127)

  • 1. The significance of the second trimester sonographic soft markers in pregnancies after normal first trimester screening.
    Kaijomaa M; Ulander VM; Ryynanen M; Stefanovic V
    Prenat Diagn; 2013 Aug; 33(8):804-6. PubMed ID: 23630127
    [No Abstract]   [Full Text] [Related]  

  • 2. Second-trimester soft markers: relation to first-trimester nuchal translucency in unaffected pregnancies.
    Miguelez J; De Lourdes Brizot M; Liao AW; De Carvalho MH; Zugaib M
    Ultrasound Obstet Gynecol; 2012 Mar; 39(3):274-8. PubMed ID: 21484908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low-risk population.
    Schuchter K; Hafner E; Stangl G; Ogris E; Philipp K
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):23-5. PubMed ID: 11489220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sonographic first trimester screening in Switzerland].
    Lapaire O; Sartorius G; Holzgreve W; Tercanli S
    Praxis (Bern 1994); 2005 Feb; 94(6):199-204. PubMed ID: 15754531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The history of the second-trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practice.
    Benacerraf BR
    Prenat Diagn; 2010 Jul; 30(7):644-52. PubMed ID: 20572106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of second-trimester ultrasound in screening for Down syndrome.
    Cuckle H; Maymon R
    Ultrasound Obstet Gynecol; 2013 Mar; 41(3):241-4. PubMed ID: 23460191
    [No Abstract]   [Full Text] [Related]  

  • 7. First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers.
    Muller F; Benattar C; Audibert F; Roussel N; Dreux S; Cuckle H
    Prenat Diagn; 2003 Oct; 23(10):833-6. PubMed ID: 14558029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down's syndrome screening with nuchal translucency.
    Hackshaw AK; Wald NJ; Haddow JE
    Lancet; 1996 Dec 21-28; 348(9043):1740. PubMed ID: 8973459
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic sonography after first-trimester Down syndrome screening.
    Krantz DA; Hallahan TW; Macri VJ; Macri JN
    Ultrasound Obstet Gynecol; 2007 Jun; 29(6):666-70. PubMed ID: 17492748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening for Down syndrome and congenital abnormalities in the first versus the second trimester].
    Lundsteen C; Brøndum-Nielsen K; Rasmussen K; Petersen GB; Jensen PK
    Ugeskr Laeger; 2000 Mar; 162(11):1580-2. PubMed ID: 10868125
    [No Abstract]   [Full Text] [Related]  

  • 11. Ultrasonographic fetal soft markers in a low-risk population: prevalence, association with trisomies and invasive tests.
    Ahman A; Axelsson O; Maras G; Rubertsson C; Sarkadi A; Lindgren P
    Acta Obstet Gynecol Scand; 2014 Apr; 93(4):367-73. PubMed ID: 24433283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of secondary ultrasound markers in the first trimester before chorionic villus sampling.
    Molina García FS; Carrillo Badillo MP; Zaragoza García EA; Fernández de Santos AG; Montoya Ventoso F
    Prenat Diagn; 2010 Dec; 30(12-13):1117-20. PubMed ID: 20949642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prenatal screening for Down's syndrome--moving from the second to the first trimester of pregnancy].
    Maymon R; Herman A; Dreazen C; Bukovsky I; Weinraub Z
    Harefuah; 1998 Feb; 134(4):296-301. PubMed ID: 10909510
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population.
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialard F; Giudicelli Y; Ville Y
    Am J Obstet Gynecol; 2006 Nov; 195(5):1379-87. PubMed ID: 16723105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing further the sonographic estimation of Down syndrome risk--how early can we go?
    Benacerraf B
    Ultrasound Obstet Gynecol; 2008 Feb; 31(2):129-31. PubMed ID: 18254162
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined first- and second-trimester screening for Down syndrome: an evaluation of proMBP as a marker.
    Rode L; Wøjdemann KR; Shalmi AC; Larsen SO; Sundberg K; Nørgaard-Pedersen B; Christiansen M; Tabor A
    Prenat Diagn; 2003 Jul; 23(7):593-8. PubMed ID: 12868091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of ultrasound markers in screening fetal trisomy 21].
    Shi XM; Fang Q; Chen BJ; Xie HN; Xie YJ; Chen JH; Wu JZ
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):81-5. PubMed ID: 23544486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of ultrasound in screening for fetal Down syndrome.
    Egan JF
    Curr Womens Health Rep; 2002 Feb; 2(1):52-8. PubMed ID: 12112983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First- and midtrimester Down syndrome screening and detection.
    Bahado-Singh RO; Choi SJ; Cheng CC
    Clin Perinatol; 2004 Dec; 31(4):677-94, v. PubMed ID: 15519423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.